The United States Court of Appeals for the Second Circuit in New York has vacated and reversed a $147 million antitrust verdict against a Chinese vitamin C manufacturer and its holding company, ruling that the district court should have granted Defendants’ original motion to dismiss.
Author
Charles Critchlow
BrowsingCharles H. Critchlow is a member of Baker McKenzie's Global Antitrust & Trade Practice Group and the North American Litigation Practice Group. He handles antitrust and commercial litigation and advice, including joint ventures, merger clearance, cartel investigations, class actions and general business litigation. Mr. Critchlow is active in the American Bar Association's Antitrust and International Law Sections. He is listed in Who's Who in America, Who's Who in the East, The World's Leading Competition and Antitrust Lawyers and New York Super Lawyers and is a frequent commentator to Law360 and Global Competition Review.